Metabolic Conditions

News Watch

Obesity and cardiovascular disease are on the rise as we have shifted away from traditional low-fat, high carbohydrate diets. Many of us living in more developed countries now eat a higher proportion of fat and a smaller proportion of carbohydrates than our ancestors once did. A new study published in the “British Medical Journal” investigates this dietary transition, providing evidence…

Megan Mouw
Megan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

Obesity and cardiovascular disease are on the rise as we have shifted away from traditional low-fat, high carbohydrate diets. Many of us living in more developed countries now eat a higher proportion of fat and a smaller proportion of carbohydrates than our ancestors once did. A new study published in the “British Medical Journal” investigates this dietary transition, providing evidence…

Megan Mouw
Megan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

With so many diets and  trends-- high fat, low fat, low carb, Paleo, vegan, etc.-- it’s hard to know which diet is best for our health. Diet greatly influences gut microbiota composition, and evidence shows how the gut microbiota metabolizes our food may matter as much as what we eat. The way our gut microbiota metabolizes fats, carbohydrates and proteins…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

With so many diets and  trends-- high fat, low fat, low carb, Paleo, vegan, etc.-- it’s hard to know which diet is best for our health. Diet greatly influences gut microbiota composition, and evidence shows how the gut microbiota metabolizes our food may matter as much as what we eat. The way our gut microbiota metabolizes fats, carbohydrates and proteins…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Occasional gastrointestinal symptoms are common in the otherwise healthy population. Most symptoms respond to dietary changes presumably via changes in the gut microbiota. Evidence shows that diet has a major impact on the gut microbiota and overall gastrointestinal health, and dietary interventions, such as consuming probiotics, especially Bifidobacterium, and the low oligo-, di-, and monosaccharide and polyol (FODMAP) diet, are…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Occasional gastrointestinal symptoms are common in the otherwise healthy population. Most symptoms respond to dietary changes presumably via changes in the gut microbiota. Evidence shows that diet has a major impact on the gut microbiota and overall gastrointestinal health, and dietary interventions, such as consuming probiotics, especially Bifidobacterium, and the low oligo-, di-, and monosaccharide and polyol (FODMAP) diet, are…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

An increasing number of studies over at least the past decade have shown, without a doubt, that our gut microbiota influences health and disease. More recently, researchers have started to focus on early life, analyzing the role that gut microbiota plays in the development of metabolic and autoimmune disorders later in life. One recent study in this regard showed infant…

Cristina Sáez
Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

An increasing number of studies over at least the past decade have shown, without a doubt, that our gut microbiota influences health and disease. More recently, researchers have started to focus on early life, analyzing the role that gut microbiota plays in the development of metabolic and autoimmune disorders later in life. One recent study in this regard showed infant…

Cristina Sáez
Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

Obesity may develop from a combination of different factors – some environmental factors, genetic predisposition and according to recent research microbiome may also play certain role in it. Obesity often co-occurs with mental health disorders, including a higher risk of developing depression and anxiety which is also true for other chronic illnesses. But although we know that neurological symptoms may…

Karina Kaplun
Karina Kaplun is a Ph.D. microbiologist and a blogger specialising in gut microbiota and probiotics. Working also as a lecturer and consultant in nutrition and healthcare. Follow Karina on Twitter and Facebook @mygutmatters and visit her blog www.mygutmatters.com

Obesity may develop from a combination of different factors – some environmental factors, genetic predisposition and according to recent research microbiome may also play certain role in it. Obesity often co-occurs with mental health disorders, including a higher risk of developing depression and anxiety which is also true for other chronic illnesses. But although we know that neurological symptoms may…

Karina Kaplun
Karina Kaplun is a Ph.D. microbiologist and a blogger specialising in gut microbiota and probiotics. Working also as a lecturer and consultant in nutrition and healthcare. Follow Karina on Twitter and Facebook @mygutmatters and visit her blog www.mygutmatters.com

Research & Practice

The gut microbiota has become a new player in the onset and development of metabolic syndrome and its associated pathologies. One gut bacterium that has been positively associated with leanness in mice and humans is Akkermansia muciniphila, which is naturally present in the gut microbiota of healthy people. In 2017, our research team at UCLouvain (Belgium) found that a pasteurized…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

The gut microbiota has become a new player in the onset and development of metabolic syndrome and its associated pathologies. One gut bacterium that has been positively associated with leanness in mice and humans is Akkermansia muciniphila, which is naturally present in the gut microbiota of healthy people. In 2017, our research team at UCLouvain (Belgium) found that a pasteurized…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Genes from the gut microbiota encode for a wide range of metabolic activities that allow commensal microbes to ferment dietary fibers and prebiotics into metabolites that include short chain fatty acids (SCFAs). Of these, propionate has been shown to trigger the secretion of gut peptides that take part in regulating appetite and glucose metabolism and reducing inflammation. Although colonic propionate…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Genes from the gut microbiota encode for a wide range of metabolic activities that allow commensal microbes to ferment dietary fibers and prebiotics into metabolites that include short chain fatty acids (SCFAs). Of these, propionate has been shown to trigger the secretion of gut peptides that take part in regulating appetite and glucose metabolism and reducing inflammation. Although colonic propionate…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Although twin research has shown that gut microbiota features a heritable component, we do not know whether gut microbial genetic variations can shape phenotypic differences that affect host health. A new study, led by Dr. Eran Segal from the Weizmann Institute of Science in Rehovot (Israel), has identified structural variations in gut microbial genomes that vary across people and are…

GMFH Editing Team
GMFH Editing Team

Although twin research has shown that gut microbiota features a heritable component, we do not know whether gut microbial genetic variations can shape phenotypic differences that affect host health. A new study, led by Dr. Eran Segal from the Weizmann Institute of Science in Rehovot (Israel), has identified structural variations in gut microbial genomes that vary across people and are…

GMFH Editing Team
GMFH Editing Team

Bariatric surgery (BS) appears as a solution for managing cardiovascular risk in people with a severe and morbid Body Mass Index (BMI > 35-40 kg/m2). Although previous research has shown that the gut microbiota profile in obesity is characterized by low microbial gene richness and is correlated with some metabolic and inflammatory markers, little is known about its contribution to…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Bariatric surgery (BS) appears as a solution for managing cardiovascular risk in people with a severe and morbid Body Mass Index (BMI > 35-40 kg/m2). Although previous research has shown that the gut microbiota profile in obesity is characterized by low microbial gene richness and is correlated with some metabolic and inflammatory markers, little is known about its contribution to…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.